O'boyle C A, Mcgee H, Hickey A, O'malley K, Joyce C R. Individual quality of life in patients undergoing hip replacement. Lancet, 1992, 339(8801): 1088-91.
 Bierbaum B E, Callaghan J J, Galante J O, Rubash H E, Tooms R E, Welch R B. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am, 1999, 81(1): 2-10.
 Rosencher N, Kerkkamp H E, Macheras G, Munuera L M, Menichella G, Barton D M, et al. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elect ive knee and hip arthroplasty in Europe. Transfusion, 2003, 43(4): 459-69.
 Young S W, Marsh D J, Akhavani M A, Walker C G, Skinner J A. Attitudes to blood transfusion post arthroplasty surgery in the United Kingdom: a national survey. Int Orthop, 2008, 32(3): 325-9.
 Busch M P, Kleinman S H, Nemo G J. Current and emerging infectious risks of blood transfusions. Jama, 2003, 289(8): 959-62.
 Vamvakas E C, Blajchman M A. Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available st rategies for their prevention. Blood, 2009, 113(15): 3406-17.
 Kennon R E, Keggi J M, Wetmore R S, Zatorski L E, Huo M H, Keggi K J. Total hip arthroplasty through a minimally invasive anterior surgical approach. J Bone Joint Surg Am, 2003, 85-A Suppl 4: 39-48.
 Berger R A, Jacobs J J, Meneghini R M, Della Valle C, Paprosky W, Rosenberg A G. Rapid rehabilitation and recovery with minimally invasive total hip arthroplasty. Clin Orthop Relat Res, 2004, (429): 239-47.
 Bremer A K, Kalberer F, Pfirrmann C W, Dora C. Soft-tissue changes in hip abductor muscles and tendons after total hip replacement: comparison betwe en the direct anterior and the transgluteal approaches. J Bone Joint Surg Br, 2011, 93(7): 886-9.
 Dunn C J, Goa K L. Tranexamic acid: a review of its use in surgery and other indications. Drugs, 1999, 57(6): 1005-32.
 Othman Y, Melebeck F, Daubresse F. Tranexamic acid in joint replacement: a randomized trial comparing intravenous oral and topical routes. Acta Orthop Belg, 2020, 86(3):397-404.
 Yi Z, Bin S, Jing Y, Zongke Z, Pengde K, Fuxing P. Tranexamic Acid Administration in Primary Total Hip Arthroplasty: A Randomized Controlled Trial of In travenous Combined with Topical Versus Single-Dose Intravenous Administration. J Bone Joint Surg Am, 2016, 98(12): 983-91.
 Fraval A, Effeney P, Fiddelaers L, Smith B, Towell B, Tran P. OBTAIN A: Outcome Benefits of Tranexamic Acid in Hip Arthroplasty. A Randomized Double-Blinded Contro lled Trial. J Arthroplasty, 2017, 32(5): 1516-19.
 Free M D, Owen D H, Pascoe E, Allen P, Yang L, Harvie P. Transfusion rates with intravenous tranexamic acid in total hip arthroplasty performed using the direct anterior approach. Hip Int, 2019, 29(5):511-515.
 Zhao H, Xiang M, Xia Y, Shi X, Pei FX, Kang P. Efficacy of oral tranexamic acid on blood loss in primary total hip arthroplasty using a direct anterior approach: a prospective randomized controlled trial. Int Orthop, 2018, 42(11):2535-2542.
 Nadler S B, Hidalgo J H, Bloch T. Prediction of blood volume in normal human adults. Surgery, 1962, 51(2): 224-32.
 Gross J B. Estimating allowable blood loss: corrected for dilution. Anesthesiology, 1983, 58(3): 277-80.
 Yamasaki S, Masuhara K, Fuji T. Tranexamic acid reduces blood loss after cementless total hip arthroplasty-prospective randomized study in 40 cases. Int Orthop, 2004, 28(2): 69-73.
 Benoni G, Fredin H, Knebel R, Nilsson P. Blood conservation with tranexamic acid in total hip arthroplasty: a randomized, double-blind study i n 40 primary operations. Acta Orthop Scand, 2001, 72(5): 442-8.
 Kayupov E, Fillingham Y A, Okroj K, Plummer D R, Moric M, Gerlinger T L, et al. Oral and Intravenous Tranexamic Acid Are Equivalent at Reducing Blood Loss Following Total Hip Arthro plasty: A Randomized Controlled Trial. J Bone Joint Surg Am, 2017, 99(5): 373-78.
 Lee Q J, Chang W Y, Wong Y C. Blood-Sparing Efficacy of Oral Tranexamic Acid in Primary Total Hip Arthroplasty. J Arthroplasty, 2017, 32(1): 139-42.
 Vles GF, et al. Hidden blood loss in direct anterior total hip arthroplasty: a prospective, double blind, randomized controlled trial on topical versus intravenous tranexamic acid. Musculoskelet Surg, 2021,105(3):267-273.
 Jungwirth-Weinberger A, Do HT, Krell EC, Valle AGD, Chalmers BP, Boettner F. Blood management in direct anterior versus posterior primary total hip arthroplasty using tranexamic acid: a matched cohort study. Arch Orthop Trauma Surg. 2021 Jun 21. doi: 10.1007/s00402-021-03965-2. Epub ahead of print. PMID: 34152489.
 Komnos GA, Manrique J, Foltz C, Klement MR, Restrepo C, Parvizi J. Transfusion Rates in Total Hip Arthroplasty Are lower in Patients with Direct Anterior Approach. Arch Bone Jt Surg, 2021,9(6):659-664.
 Alshryda S, Mason J, Sarda P, Nargol A, Cooke N, Ahmad H, et al. Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total hi p replacement: a randomized controlled trial (TRANX-H) . J Bone Joint Surg Am, 2013, 95(21): 1969-74.
 El Beheiry H, Lubberdink A, Clements N, Dihllon K, Sharma V. Tranexamic acid administration to older patients undergoing primary total hip arthroplasty conserves hemoglobin and reduces blood loss. Can J Surg, 2018, 61(3): 177-84.
 Nishihara S, Hamada M. Does tranexamic acid alter the risk of thromboembolism after total hip arthroplasty in the absence of routine chemical thromboprophylaxis? . Bone Joint J, 2015, 97-b (4): 458-62.